Gut microbes may mediate beneficial effects of low-carb diet on irritable bowel syndrome

Researchers have found that a diet low in fermentable carbohydrates can alter the human microbiota in ways that influence the expression of genes involved in inflammation and intestinal integrity.

Personalized human gut microbiome responses to dietary intervention through a multiomic perspective

Emily Hollister discussed how Diversigen demonstrates the rapidity of microbial gene expression changes potentially impacting host-microbiome interactions.

MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program

With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases.

Novozymes and Chr. Hansen to merge and create a leading global biosolutions partner

The new group will have annual revenues of approximately 3.5 billion euros ($3.7 billion), the companies said.

How the tumor microbiota may reduce the efficacy of cancer drugs

A recent study confirms that 5-FU exerts part of its anti-cancer effects through inhibiting the growth of F. nucleatum, the commensal associated with colorectal cancer progression.

Federation Bio Administers First Dose in Phase 1 Clinical Trial Evaluating Investigational Bacterial Cell Therapy

FB-001 is a rationally designed consortium of 148 defined bacterial strains with unprecedented diversity, representing a complete microbiome replacement

A closer look at the microbiota of the small intestine

A recent study confirms that ileum and colon have a distinct microbiota: unlike the bacterial composition of the colon, the ileum is subject to frequent fluctuations.

Benjamin Hadida – Translating the potential of . Faecalibacterium prausnitzii In Crohn’s Disease to the clinical Sstage

Benjamin Hadida discusses how to validate innovative clinical trial design and overcome challenges of robust-large scale manufacturing.

Gut bacteria influence response to cocaine in mice

The findings of a new research may help to inform therapies to modulate brain circuits that are involved in substance use disorders.

COVID-19 may disrupt gut microbiota to increase risk for other infections

Microbiota alterations in COVID-19 patients appeared to be associated with secondary infections of the blood by gut bacteria: four cases of positive blood cultures of Staphylococcus species were identified.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.